{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-14T12:24:38.509536+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade) (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOaE56OUloZWVVc3dXc2h4bzdmdnFrOFV5MVUtRmZlSWs0amFNUTdmelJFdWNVZjlRdFNxUkFtSFZHekMySktjWTNnWTlBMjZKa3gxbTlRWVM3cHg1djFJcXFoclBVMnh2MGRfcGRUa2h5dDVyc01hUktWYW9QTmFMRTlWVms3SktER25ISi1DR0VKMzZfLXc2c1N4TDdRNkhNV0dKejVyMjJyaS02VVpUZnNUOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOaE56OUloZWVVc3dXc2h4bzdmdnFrOFV5MVUtRmZlSWs0amFNUTdmelJFdWNVZjlRdFNxUkFtSFZHekMySktjWTNnWTlBMjZKa3gxbTlRWVM3cHg1djFJcXFoclBVMnh2MGRfcGRUa2h5dDVyc01hUktWYW9QTmFMRTlWVms3SktER25ISi1DR0VKMzZfLXc2c1N4TDdRNkhNV0dKejVyMjJyaS02VVpUZnNUOA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade) (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-11T20:47:24+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQODBvYnVaZUlPd2FCMWdvTlN1bzk0YkhOdVdUeEdTN1pNOTN0N3hPbnhtazdMSk1zcWswbHRwZGZ5dTc1TGJLaVNVek9hMV9PTl82VkZTSEwzMklhblEyTUFYRXFsQUZhRDFCZ0RZdUx0NE5RaDRHNnREYTFQU2hxdTREMFYxVXB6dFZ1QzlncTJGSVU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQODBvYnVaZUlPd2FCMWdvTlN1bzk0YkhOdVdUeEdTN1pNOTN0N3hPbnhtazdMSk1zcWswbHRwZGZ5dTc1TGJLaVNVek9hMV9PTl82VkZTSEwzMklhblEyTUFYRXFsQUZhRDFCZ0RZdUx0NE5RaDRHNnREYTFQU2hxdTREMFYxVXB6dFZ1QzlncTJGSVU?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-12T10:50:42+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex HQ refinanced for $1 billion - The Business Journals",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxObkN5ZjJwc1hmVjlsM2VmaUlVZmEySHpjV2dYU2xxcDRsXzduNzE2M3BtcFlCbEJiV0lxeDFMSGtvQ2ZSdGhQOXY4dXVad0p3YVJRYmxnTElXQ3QyOU1HTkhtejZxM0ljVlZoQVZINzFVMG9CbnFLR3dDMF9Ib2RJRXBrVDlVVDQ5MWR4RksyMlM4dkl0cm9OYkh6RXBQbGRKRlVJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxObkN5ZjJwc1hmVjlsM2VmaUlVZmEySHpjV2dYU2xxcDRsXzduNzE2M3BtcFlCbEJiV0lxeDFMSGtvQ2ZSdGhQOXY4dXVad0p3YVJRYmxnTElXQ3QyOU1HTkhtejZxM0ljVlZoQVZINzFVMG9CbnFLR3dDMF9Ib2RJRXBrVDlVVDQ5MWR4RksyMlM4dkl0cm9OYkh6RXBQbGRKRlVJ?oc=5\" target=\"_blank\">Vertex HQ refinanced for $1 billion</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Business Journals</font>",
      "published": "2025-08-12T17:49:00+00:00",
      "source": "The Business Journals"
    },
    {
      "title": "Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-12T18:34:19+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOSVlhcHBheHg5cUx3dXBnWmR2RkVGbzROYm9nY0pSelM0MEVfb0FKYzRYeUp5c1F2ODhkbGZrdjJONkxsTi1ULXpxajlPWGVWd0tYV3htUFNBNWJrZk1KRjZGR192WTBwX0VHQUhsV0dmZUREcVdRTWxGTnY4dWh3VS1DV09aSlpjbFdFOHY2a3F1VmxSWm04SjRSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxOSVlhcHBheHg5cUx3dXBnWmR2RkVGbzROYm9nY0pSelM0MEVfb0FKYzRYeUp5c1F2ODhkbGZrdjJONkxsTi1ULXpxajlPWGVWd0tYV3htUFNBNWJrZk1KRjZGR192WTBwX0VHQUhsV0dmZUREcVdRTWxGTnY4dWh3VS1DV09aSlpjbFdFOHY2a3F1VmxSWm04SjRSQQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-13T13:00:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investopedia"
    },
    {
      "title": "People With Severe Diabetes Are Cured in Small Trial of New Drug - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPN01iYzhrenNua0dTbXIwUjNZaDJQS0RKT0k3VWloUmRGc3g5TkVlYVk3MHRQRURqbmRGV0ZlQmctY2R3cEdXcERmRzZHcnNkZzgySWkta2hMbzI1bEZQYUtSczJXSGVNbmlYWU9qQTBxQ1BzS3VabWFoUjY0Z0QxN1M3VXU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPN01iYzhrenNua0dTbXIwUjNZaDJQS0RKT0k3VWloUmRGc3g5TkVlYVk3MHRQRURqbmRGV0ZlQmctY2R3cEdXcERmRzZHcnNkZzgySWkta2hMbzI1bEZQYUtSczJXSGVNbmlYWU9qQTBxQ1BzS3VabWFoUjY0Z0QxN1M3VXU?oc=5\" target=\"_blank\">People With Severe Diabetes Are Cured in Small Trial of New Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-06-21T07:00:00+00:00",
      "source": "The New York Times"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Bullish Fundamentals and Technicals Suggest Rising Momentum - AInvest",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUmJrMm4zdWpQQmJ0MFdzYUhnUXZGWEZOU0doeWtFQmltSThYbTRRVmQzUjhZSjlfZmVBeXBKOHNRSlVZUWJlbkdDNVc5NkdueFdnd2o2T0JiODl5ajJOUy12WFBaampaUzZidDFxbHdpbUlUQ2pFcmdiYkM5dVVfV0w5c0xzUGxjY1pZUWplZU9ldnk2QlFuZmY5cHhxTHBiaDR1TWFEMWlhSUhVSVNhMWZYV2Z1TmZfcXZMcFhLbTVxY3N6UTBVd3VWRVVQZUdTVmc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUmJrMm4zdWpQQmJ0MFdzYUhnUXZGWEZOU0doeWtFQmltSThYbTRRVmQzUjhZSjlfZmVBeXBKOHNRSlVZUWJlbkdDNVc5NkdueFdnd2o2T0JiODl5ajJOUy12WFBaampaUzZidDFxbHdpbUlUQ2pFcmdiYkM5dVVfV0w5c0xzUGxjY1pZUWplZU9ldnk2QlFuZmY5cHhxTHBiaDR1TWFEMWlhSUhVSVNhMWZYV2Z1TmZfcXZMcFhLbTVxY3N6UTBVd3VWRVVQZUdTVmc?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Bullish Fundamentals and Technicals Suggest Rising Momentum</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-14T03:11:43+00:00",
      "source": "AInvest"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-13",
      "close": 395.9200134277344
    },
    "history": [
      {
        "date": "2025-08-05",
        "close": 374.9800109863281
      },
      {
        "date": "2025-08-06",
        "close": 385.6499938964844
      },
      {
        "date": "2025-08-07",
        "close": 375.6300048828125
      },
      {
        "date": "2025-08-08",
        "close": 366.5400085449219
      },
      {
        "date": "2025-08-11",
        "close": 374.4599914550781
      },
      {
        "date": "2025-08-12",
        "close": 387.7699890136719
      },
      {
        "date": "2025-08-13",
        "close": 395.9200134277344
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}